FFO
YARW

Fortitude Family Office’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Fortitude Family Office’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14
Closed -$228 – 2141
2025
Q3 		$228 Buy
+14
New +$458 ﹤0.01% 1916

Other funds holding YARW

SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fortitude Family Office's YARW Position: Q4 2025 in Review

Fortitude Family Office sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q4 2025, closing a stake of 14 shares — an estimated $228 sold.

Fortitude Family Office first reported a position in YARW in Q3 2025 and held it in 1 quarter. The position peaked at $228 in Q3 2025. 41 funds tracked by Wall St. Rank hold YARW as of Q4 2025.

  • Fortitude Family Office reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
  • Fortitude Family Office sold 14 Yarrow Bioscience, Inc. Common Stock shares in Q4 2025, an estimated $228.
  • Fortitude Family Office first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2025 and held it in 1 quarter.
  • Fortitude Family Office's Yarrow Bioscience, Inc. Common Stock position peaked at $228 in Q3 2025.
  • 41 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q4 2025.

Based on Fortitude Family Office's 13F filing for Q4 2025, filed 15 Jan 2026.